Bacterial Infections  >>  amikacin inhalation solution (NKTR-061)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amikacin inhalation solution (NKTR-061) / Nektar Therap
INHALE 1, NCT01799993 / 2013-001048-73: Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

Completed
3
725
Canada, US, RoW
Amikacin Inhalation Solution (BAY41-6551), Aerosolized Placebo
Bayer, Nektar Therapeutics
Pneumonia, Bacterial
04/17
04/17
NCT00805168: Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

Completed
3
461
Japan, Europe, RoW
Amikacin Inhalation Solution (BAY41-6551), Aerosolized Placebo
Bayer, Nektar Therapeutics, Novartis Pharmaceuticals
Pneumonia, Bacterial
04/17
04/17

Download Options